Find a Clinical Trial

Karyopharm is committed to developing novel treatment options to patients in need. Search here for ongoing clinical trials evaluating Karyopharm’s investigational medicines. For more information about our clinical trials, please reach out to clinicaltrials@karyopharm.com

Karyopharm-Sponsored Trials Investigator-Sponsored Trials

Evaluating SINE KPT-330 in Treating Patients With Melanoma That Cannot Be Removed By Surgery

This phase I clinical trial studies the side effects of selinexor in treating patients with melanoma that cannot be removed by surgery. Drugs used in chemotherapy, such as selinexor, may stop the growth of tumor cells, by stopping them from dividing.
Primary Condition
Melanoma
Sponsor
Kari Kendra
Status
Completed
Drug
selinexor
Phase
Phase1
Age Group
18 Years+
Primary Condition
Melanoma